glutathione for cirrhosis disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease Novel Use for Oral Glutathione:
Description
Treated animals showed improved load-to-failure, reduced inflammatory infiltrates, and enhanced tendon-to-bone healing
The catch: no published, peer-reviewed human randomized controlled trial exists for BPC-157 as of March 2026
The program is structured around a maintenance philosophy, not a fixed end date
doi:10.1002/jor.21107 Preparation and storage Research-only handling information
